The Prescription Drug Affordability Board (PDAB) moved its next meeting from September 18 to October 2 due to unforeseen scheduling issues and lack of a quorum. The agenda has been updated to reflect this change. Please note the “Medicare MFP modeling presentation and SB 192 upper payment limit discussion” by PDAB staff and Myers and Stauffer on the agenda. You must register in advance of the meeting to participate.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) posted the draft agenda for its next meeting on September 18. Please note the “Medicare MFP modeling presentation and SB 192 upper payment limit discussion” by PDAB staff and Myers and Stauffer on the draft agenda. You must register in advance of the meeting to participate.
Also in Oregon, NACDS, as a participant in the PBM Working Group, submitted a letter to Rep. Rob Nosse (D), Chair, House Behavioral Health and Health Care Committee, to provide comments and pharmacy reimbursement concepts in advance of the next working group meeting scheduled to be held on September 18.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) posted the draft agenda for its next meeting on August 21. Please note the presentation by Myers and Stauffer titled “SB 192 Upper Payment Limit Deliverable” on the draft agenda. You must register in advance of the meeting to participate.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) posted the agenda and meeting materials for its next meeting on July 24. Please register in advance of the meeting.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) posted the agenda for its next meeting on July 24. Please register in advance of the meeting.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
NACDS submitted a letter to the Prescription Drug Affordability Board (PDAB) expressing concern about the inclusion of vaccines in PDAB affordability reviews and strongly encouraging the removal of vaccines as eligible for affordability reviews by the PDAB. Both the Affordable Care Act and the Inflation Reduction Act mandate that all vaccines recommended by CDC’s Advisory Committee on Immunization Practices (ACIP) are covered without cost-sharing for all publicly and privately insured individuals.
Also in Oregon, the Prescription Drug Affordability Board (PDAB) posted the agenda and meeting materials for its next meeting on June 26. Please register in advance of the meeting.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy will meet on June 12-14. The agenda and meeting materials are available online.
Also in Oregon, the following individuals have been appointed to the Board of Pharmacy: Amy Kirkbride with Kaiser Permanente, Victoria Kroeger with Walgreens and Ana Pinedo.
Finally in Oregon, the Division of Financial Regulation announced this proposed rulemaking. These proposed rules implement 2023 Oregon Enrolled SB 797, Oregon Laws 2023, chapter 113, which requires certain health insurance policies to provide coverage for prosthetic and orthotic devise as defined in the bill.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Board of Pharmacy posted the May 2024 newsletter with updates on the 2024 legislative session and rulemaking.
Also in Oregon, Emma Sandoe, PhD, MPH, has been appointed as the permanent director of Oregon’s Medicaid program, effective July 24. Since 2019, Dr. Sandoe has served in North Carolina’s Medicaid program most recently as the Deputy Director of Medicaid Policy.
Finally in Oregon, the Board of Pharmacy is seeking licensed pharmacists, physicians and advanced practice registered nurses to serve as subject matter experts (SMEs) for the Public Health & Pharmacy Formulary Advisory Committee. The board utilizes SMEs to develop and revise protocols in the Protocol Compendium per OAR 855-115-0345. SMEs will be selected using an application process to ensure representation of diverse practice settings. If you would like to serve as a SME for the PHPFAC, please complete the online form by June 5; scroll down the webpage to access the online volunteer form. Individuals selected will receive confirmation by June 21. Note: Current SMEs, please complete and submit the form so that the board has your current contact information.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Prescription Drug Affordability Board (PDAB) has extended the deadline for the Upper Payment Limit (UPL) survey. The survey is being used to gather information about concerns, challenges, impacts, and opportunities related to the UPL process in Oregon. If you have not yet submitted a response, please do so by May 31. You can access the survey at the following location: https://mslc.qualtrics.com/jfe/form/SV_39ijG1FM8LzFDMy
Please send any questions to the project team at PDAB@DCHB.Oregon.gov.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.